ACCEL: Charles Resor, MD

ACCEL: Ori Ben-Yahuda, MD

ACCEL: L. Kristin Newby, MD, FACC

ACCEL: Win-Kuang Shen, MD

Regenerating Functional Heart Mass and a Comparitive Study in PAD: Updating a Pair of Cover Stories

Will Big Data Shine Light at the End of the Tunnel for HDL?

Many Patients with AF (Really) Don’t Know Their Risk Factors

Study Suggests it’s Time to Rethink the Design of the Cardiac ICU

Risk of MACE in Recent PCI Patients Requiring Noncardiac Surgery

Study Raises Important Questions Regarding the 30-day Readmission Metric for HF

Future of HeART Interventions: PIONEER AF-PCI

ACCEL: C. Michael Gibson, MD

ACCEL: Brian Ference, MD

ACCEL: Valentine Fuster, MD, PhD, MACC

ACCEL: David Dixon, PharmD

Is the Controversy Over? CV Risk and White Coat Hypertension

Evolut R study: Size Matters and Having Various Sizes Available Matters in TAVR

The YELLOW II IMaging Study

Operator Experience and Volume on Outcomes After Left Main PCI

Vorapaxar and Peripheral Revascularization: More Than Purely Anti-Thrombotic Effects?

Benchmarking lifestyle modification for Youth Dyslipidemia

The Conundrum of Patients with Chronic Kidney Disease

Percutaneous Mechanical Circulatory Support vs. IABP for Cardiogenic Shock

First-in-Human Experience with a Novel Temporary Pacing Lead

The Changing Landscape of CVD Trials

Outcomes from the RevElution Study

To Operate or Not To Operate After DES: Is It Still A Question?

TAVR for Pure Native Aortic Valve Regurgitation: Where are We?

DAPT Duration After PCI: A Complex Decision or Not?

Cover Update: 1-year Feasibility Data for a Transcatheter Pulmonary Valve